Page last updated: 2024-08-23

brimonidine tartrate and Bile Duct Cancer

brimonidine tartrate has been researched along with Bile Duct Cancer in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Alpini, G; Francis, H; Glaser, S; Kanno, N; Lesage, G; Phinizy, JL	1

Other Studies

1 other study(ies) available for brimonidine tartrate and Bile Duct Cancer

Article	Year
Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities. Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:6 Topics: Adrenergic alpha-Agonists; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blotting, Western; Brimonidine Tartrate; Cell Division; Cholangiocarcinoma; Cyclic AMP; Humans; Inositol 1,4,5-Trisphosphate; MAP Kinase Signaling System; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Quinoxalines; ras Proteins; Receptors, Adrenergic, alpha-2; Tumor Cells, Cultured	2002

Article

Year

Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities.

Hepatology (Baltimore, Md.), 2002, Volume: 35, Issue:6

Topics: Adrenergic alpha-Agonists; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Blotting, Western; Brimonidine Tartrate; Cell Division; Cholangiocarcinoma; Cyclic AMP; Humans; Inositol 1,4,5-Trisphosphate; MAP Kinase Signaling System; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins c-raf; Quinoxalines; ras Proteins; Receptors, Adrenergic, alpha-2; Tumor Cells, Cultured

2002